Screener / SEC EDGAR /CIK 0001179929 /10-K filed Feb 10, 2026, compared with Feb 11, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Financials · Health Insurance

Molina Healthcare, Inc. MOH

Compare with peers Embed
Earnings releases

Latest results release: Oct 21, 2026

8-K item 2.02, exhibit 99

What MOH's management wrote with each quarter's results: the press release and, when the company files them, its prepared remarks or the call transcript. The call itself is not filed with SEC, so most quarters have the release only.

Adjusted vs GAAP earnings per share

In the company's own words · read from each release, never computed

In its release of Oct 21, 2026, MOH reported $0.73 per share under GAAP and $0.89 on its own adjusted basis: the adjusted number is +22% above GAAP.

GAAP EPS $3.70, release Feb 7, 2024: (NYSE: MOH) (the “Company”) today reported fourth quarter 2023 GAAP earnings per diluted share of $3.70 and adjusted earnings per diluted share of $4.38. Adjusted EPS $4.38, release Feb 7, 2024: (NYSE: MOH) (the “Company”) today reported fourth quarter 2023 GAAP earnings per diluted share of $3.70 and adjusted earnings per diluted share of $4.38. +18% 2024-02 GAAP EPS $5.17, release Apr 24, 2024: (NYSE: MOH) (the “Company”) today reported first quarter 2024 GAAP earnings per diluted share of $5.17 and adjusted earnings per diluted share of $5.73. Adjusted EPS $5.73, release Apr 24, 2024: (NYSE: MOH) (the “Company”) today reported first quarter 2024 GAAP earnings per diluted share of $5.17 and adjusted earnings per diluted share of $5.73. +11% 2024-04 GAAP EPS $5.17, release Jul 24, 2024: (NYSE: MOH) (the “Company”) today reported second quarter 2024 GAAP earnings per diluted share of $5.17 and adjusted earnings per diluted share of $5.86. Adjusted EPS $5.86, release Jul 24, 2024: (NYSE: MOH) (the “Company”) today reported second quarter 2024 GAAP earnings per diluted share of $5.17 and adjusted earnings per diluted share of $5.86. +13% 2024-07 GAAP EPS $5.65, release Oct 23, 2024: (NYSE: MOH) (the “Company”) today reported third quarter 2024 GAAP earnings per diluted share of $5.65 and adjusted earnings per diluted share of $6.01. Adjusted EPS $6.01, release Oct 23, 2024: (NYSE: MOH) (the “Company”) today reported third quarter 2024 GAAP earnings per diluted share of $5.65 and adjusted earnings per diluted share of $6.01. +6% 2024-10 GAAP EPS $4.44, release Feb 5, 2025: (NYSE: MOH) (the “Company”) today reported fourth quarter 2024 GAAP earnings per diluted share of $4.44 and adjusted earnings per diluted share of $5.05. Adjusted EPS $5.05, release Feb 5, 2025: (NYSE: MOH) (the “Company”) today reported fourth quarter 2024 GAAP earnings per diluted share of $4.44 and adjusted earnings per diluted share of $5.05. +14% 2025-02 GAAP EPS $5.45, release Apr 23, 2025: (NYSE: MOH) (the “Company”) today reported first quarter 2025 GAAP earnings per diluted share of $5.45 and adjusted earnings per diluted share of $6.08. Adjusted EPS $6.08, release Apr 23, 2025: (NYSE: MOH) (the “Company”) today reported first quarter 2025 GAAP earnings per diluted share of $5.45 and adjusted earnings per diluted share of $6.08. +12% 2025-04 GAAP EPS $4.75, release Jul 23, 2025: (NYSE: MOH) (the “Company”) today reported second quarter 2025 GAAP earnings per diluted share of $4.75 and adjusted earnings per diluted share of $5.48. Adjusted EPS $5.48, release Jul 23, 2025: (NYSE: MOH) (the “Company”) today reported second quarter 2025 GAAP earnings per diluted share of $4.75 and adjusted earnings per diluted share of $5.48. +15% 2025-07 GAAP EPS $1.51, release Oct 22, 2025: (NYSE: MOH) (the “Company”) today reported third quarter 2025 GAAP earnings per diluted share of $1.51 and adjusted earnings per diluted share of $1.84. Adjusted EPS $1.84, release Oct 22, 2025: (NYSE: MOH) (the “Company”) today reported third quarter 2025 GAAP earnings per diluted share of $1.51 and adjusted earnings per diluted share of $1.84. +22% 2025-10 GAAP EPS $-3.15, release Feb 5, 2026: (NYSE: MOH) (the “Company”) today reported fourth quarter 2025 GAAP loss per diluted share of $3.15 and adjusted loss per diluted share of $2.75. Adjusted EPS $-2.75, release Feb 5, 2026: (NYSE: MOH) (the “Company”) today reported fourth quarter 2025 GAAP loss per diluted share of $3.15 and adjusted loss per diluted share of $2.75. 2026-02 GAAP EPS $0.27, release Apr 22, 2026: (NYSE: MOH) (the “Company”) today reported first quarter 2026 GAAP income per diluted share of $0.27 and adjusted income per diluted share of $2.35. Adjusted EPS $2.35, release Apr 22, 2026: (NYSE: MOH) (the “Company”) today reported first quarter 2026 GAAP income per diluted share of $0.27 and adjusted income per diluted share of $2.35. +770% 2026-04 GAAP EPS $1.19, release Jul 22, 2026: (NYSE: MOH) (the “Company”) today reported second quarter 2026 GAAP income per diluted share of $1.19 and adjusted income per diluted share of $1.51. Adjusted EPS $1.51, release Jul 22, 2026: (NYSE: MOH) (the “Company”) today reported second quarter 2026 GAAP income per diluted share of $1.19 and adjusted income per diluted share of $1.51. +27% 2026-07 GAAP EPS $0.73, release Oct 21, 2026: (NYSE: MOH) (the “Company”) today reported third quarter 2026 GAAP income per diluted share of $0.73 and adjusted income per diluted share of $0.89. Adjusted EPS $0.89, release Oct 21, 2026: (NYSE: MOH) (the “Company”) today reported third quarter 2026 GAAP income per diluted share of $0.73 and adjusted income per diluted share of $0.89. +22% 2026-10
GAAP EPSAdjusted EPS, as the company defines itThe figure on top is how far adjusted is from GAAP. Click a bar for the sentence.
The company's words, latest release
(NYSE: MOH) (the “Company”) today reported third quarter 2026 GAAP income per diluted share of $0.73 and adjusted income per diluted share of $0.89. release

Both numbers are read from the words of each release (usually the highlights), never computed by us; hover a number for its sentence. Quarters where the release gives them only in a table are not shown. The company decides what "adjusted" leaves out; the full reconciliation is in the release.

Read and search

Every release, in full · linked to sec.gov

Press release Oct 21, 2026 · EX-99.1

Investor Contact: Jeffrey Geyer, [email protected] ,

Open on SEC

Investor Contact: Jeffrey Geyer, [email protected] , 305-317-3012

Media Contact: Caroline Zubieta, [email protected] , 562-542-1845 Molina Healthcare Reports Third Quarter 2026 Financial Results

– Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported third quarter 2026 GAAP income per diluted share of $0.73 and adjusted income per diluted share of $0.89. Financial results are summarized below:

• As of September 30, 2026, the Company served approximately 4.9 million members.

• Premium revenue was approximately $10.5 billion for the third quarter of 2026.

• Third quarter 2026 GAAP income per diluted share was $0.73 and adjusted income per diluted share was $0.89.

• The Company reaffirmed its full year 2026 guidance of expected premium revenue of approximately $42 billion and adjusted earnings of at least $5.25 per diluted share.

“We are pleased with our third quarter results in this challenging environment and reaffirm our full year guidance,” said Joseph Zubretsky, President and Chief Executive Officer. “With the apparent plateauing of medical cost trend, which remains at elevated levels, and the strength of recent rate updates for 2027, we believe we are likely observing the beginning of the turn in Medicaid margins.” -MORE- Molina Healthcare, Inc. Reports Third Quarter 2026 Financial Results

Premium revenue was approximately $10.5 billion for the third quarter of 2026, a decrease of 4% year over year. The lower premium revenue reflects the impact of lower membership in Medicaid and Marketplace, partially offset by rate updates.

GAAP net income for the third quarter of 2026 was $38 million, or $0.73 per diluted share, a decrease of 52% year over year. Adjusted net income for the third quarter of 2026 was $46 million, or $0.89 per diluted share, a decrease of 53% year over year. The decrease is attributed mainly to a higher consolidated MCR.

• The Medicaid MCR for the third quarter of 2026 was 93.0% and in line with the Company’s expectations, reflecting rate updates and stable medical cost trend.

• The Medicare MCR for the third quarter of 2026 was 93.0% and in line with the Company’s expectations, reflecting stable medical cost trend.

• The Marketplace MCR for the third quarter of 2026 was 92.5% and in line with normal seasonality and the Company’s expectations.

The G&A ratio and the adjusted G&A ratio for the third quarter of 2026 were 6.4% and 6.3%, respectively, reflecting continued operating discipline.

Cash and investments at the parent company were approximately $608 million as of September 30, 2026, compared to $223 million as of December 31, 2025.

Days in claims payable at September 30, 2026, was 44, consistent with June 30, 2026.

Operating cash flow for the nine months ended September 30, 2026, was $629 million, compared to an outflow of $237 million for the nine months ended September 30, 2025. The increase compared to the prior year was driven mainly by lower government receivable and payable settlements in 2026.

Premium revenue guidance for the full year is unchanged at approximately $42 billion.

The Company expects its full year 2026 GAAP earnings to be at least $2.38 per diluted share and reaffirmed its full year 2026 adjusted earnings of at least $5.25 per diluted share. Guidance metrics across all segments are also reaffirmed. Full year earnings guidance includes a loss of $1.50 per share due to the implementation of the new Florida Medicaid contract in the fourth quarter of 2026 and a loss of $1.00 per share due to performance of the traditional MAPD product, which the Company previously announced it will exit for 2027. -MORE- Molina Healthcare, Inc. Reports Third Quarter 2026 Financial Results

Management will host a conference call and webcast to discuss Molina Healthcare’s third quarter ended September 30, 2026 results, at 8:00 a.m. Eastern Time on Thursday, October 22, 2026. The number to call for the interactive teleconference is (877) 883-0383 and the confirmation number is 6534841. A telephonic replay of the conference call will be available through Thursday, October 29, 2026, by dialing (855) 669-9658 and entering confirmation number 4361465 . A live audio broadcast of this conference call will be available on Molina Healthcare’s investor relations website, investors.molinahealthcare.com . A 30-day online replay will be available approximately an hour following the conclusion of the live broadcast.

Molina Healthcare, Inc., a FORTUNE 500 company, provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. For more information about Molina Healthcare, please visit molinahealthcare.com .

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

This earnings release and the Company’s accompanying oral remarks contain forward-looking statements. The Company intends such forward-looking statements to be covered under the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements provide current expectations of future events based on certain assumptions, and all statements other than statements of historical fact contained in this earnings release and the Company’s accompanying oral remarks may be forward-looking statements. In some cases, you can identify forward-looking statements by words such as “guidance,” “future,” “anticipates,” “assumes,” “believes,” “embedded,” “estimates,” “expects,” “growth,” “intends,” “plans,” “predicts,” “projects,” “will,” “would,” “could,” “can,” “may,” or the negative of these terms or other similar expressions. Forward-looking statements contained in this earnings release include, but are not limited to, statements regarding the Company’s 2026 guidance and long-term performance outlook, trends with respect to rates, pretax margins, utilization, and medical costs, including the timing thereof and the anticipated impact on the Company’s business, and our management’s plans and objectives for future operations and business strategy.

Actual results could differ materially due to numerous known and unknown risks and uncertainties. These risks and uncertainties are discussed under the headings “Forward-Looking Statements,” and “Risk Factors,” in the Company’s Annual Report on Form 10‑K for the year ended December 31, 2025, which is on file with the U.S. Securities and Exchange Commission (the “SEC”), and in the Company’s other filings with the SEC, including its Quarterly Reports on Form 10-Q for the period ended March 31, 2026 and June 30, 2026 filed with the SEC and Quarterly Report on Form 10-Q for the period ended September 30, 2026, to be filed with the SEC.

These reports can be accessed under the investor relations tab of the Company’s website or on the SEC’s website at sec.gov . Given these risks and uncertainties, the Company can give no assurances that its forward-looking statements will prove to be accurate, or that any other results or developments projected or contemplated by its forward-looking statements will in fact occur, and the Company cautions investors not to place undue reliance on these statements. All forward-looking statements in this release represent the Company’s judgment as of October 21, 2026, and, except as otherwise required by law, the Company disclaims any obligation to update any forward-looking statement to conform the statement to actual results or changes in its expectations. -MORE- Molina Healthcare, Inc. Reports Third Quarter 2026 Financial Results

September 30, 2026 Unaudited (Dollars in millions, ASSETS except per-share December 31, Current assets: amounts) 2025 ────────────────────────────────────────────────────────────────────────────── Cash and cash $ 4,479 $ 4,248 equivalents Investments 4,100 4,008 Receivables 3,359 3,533 Prepaid expenses and other current 576 655 assets Total current assets 12,514 12,444 Property, equipment, and capitalized 324 301 software, net Goodwill and intangible assets, 2,073 2,195 net Restricted 345 299 investments Deferred income 267 178 taxes, net Other assets 129 147 Total assets $ 15,652 $ 15,564 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Medical claims and $ 4,988 $ 4,887 benefits payable Amounts due 1,141 1,326 government agencies Accounts payable, accrued liabilities 1,183 1,093 and other Deferred revenue 82 66 Total current 7,394 7,372 liabilities Long-term debt 3,771 3,766 Finance lease 179 184 liabilities Other long-term 153 173 liabilities Total liabilities 11,497 11,495 Stockholders’ equity: Common stock, $0.001 par value, 150 million shares authorized; outstanding: — — 52 million shares at September 30, 2026, and 51 million at December 31, 2025 Preferred stock, $0.001 par value; 20 million shares authorized, no — — shares issued and outstanding Additional paid-in 536 452 capital Accumulated other comprehensive (loss) -95 15 income Retained earnings 3,714 3,602 Total stockholders’ 4,155 4,069 equity Total liabilities and stockholders’ $ 15,652 $ 15,564 equity

Nine Months Ended September 30, 2026 Operating activities: (In millions) 2025 ────────────────────────────────────────────────────────────────────────────── Net income $ 112 $ 632 Adjustments to reconcile net income to net cash provided by (used in) operating activities: Depreciation and amortization 117 151 Deferred income taxes -54 37 Share-based compensation 85 27 Impairment 93 — Other, net -21 -2 Changes in operating assets and liabilities: Receivables 174 -118 Prepaid expenses and other current 11 -25 assets Medical claims and benefits 101 -157 payable Amounts due government agencies -185 -467 Accounts payable, accrued liabilities 88 -195 and other Deferred revenue 16 -44 Income taxes 92 -76 Net cash provided by (used in) operating 629 -237 activities Investing activities: Purchases of investments -1,245 -607 Proceeds from sales and maturities of 1,020 1,017 investments Purchases of property, equipment, and -94 -102 capitalized software Net cash paid in business — -245 combinations Other, net -9 19 Net cash (used in) provided by investing -328 82 activities Financing activities: Proceeds from borrowings under credit — 1,100 facility and term loans Common stock purchases — -1,000 Repayment of credit facility and term — -360 loans Common stock withheld to settle employee -15 -37 tax obligations Other, net -16 35 Net cash used in financing -31 -262 activities Net increase (decrease) in cash, cash equivalents, and restricted 270 -417 cash and cash equivalents Cash, cash equivalents, and restricted cash and cash equivalents at 4,348 4,741 beginning of period Cash, cash equivalents, and restricted cash and cash equivalents at $ 4,618 $ 4,324 end of period

(Dollars in millions) The Company’s claims liabilities include additional reserves to account for moderately adverse conditions based on historical experience and other factors including, but not limited to, variations in claims payment patterns, changes in utilization and cost trends, known outbreaks of disease, and large claims. The Company’s reserving methodology is consistently applied across all periods presented. The amounts displayed for “Components of medical care costs related to: Prior year” represent the amounts by which the original estimates of claims and benefits payable at the beginning of the year were more than the actual liabilities based on information (principally the payment of claims) developed since those liabilities were first reported. The following table presents the components of the change in medical claims and benefits payable for the periods indicated:

Nine Months Ended September 30, 2026 Unaudited 2025 ────────────────────────────────────────────────────────────────────────────── Medical claims and benefits payable, $ 4,887 $ 4,640 beginning balance Components of medical care costs related to: Current year 28,781 29,476 Prior year -352 -124 Total medical care costs 28,429 29,352 Payments for medical care costs related to: Current year 24,692 25,425 Prior year 3,963 4,059 Total paid 28,655 29,484 Acquired balances, net of — 361 post-acquisition adjustments Change in non-risk and other 327 -25 payables Medical claims and benefits payable, $ 4,988 $ 4,844 ending balance Days in Claims Payable(1) 44 46

(1) The Company calculates Days in Claims Payable using claims incurred but not paid, or IBNP, and other fee-for-service payables included in medical claims and benefits payable, and quarterly fee-for-service related costs included in medical care costs within the Company’s consolidated financial statements. -MORE- Molina Healthcare, Inc. Reports Third Quarter 2026 Financial Results

(In millions, except per diluted share amounts) The Company believes that certain non-GAAP (generally accepted accounting principles) financial measures are useful supplemental measures to investors in comparing the Company’s performance to the performance of other public companies in the health care industry. The non-GAAP financial measures are also used internally to enable management to assess the Company’s performance consistently over time. These non-GAAP financial measures, presented below, should be considered as supplements to, and not as substitutes for or superior to, GAAP measures.

represent additions and deductions to GAAP net income as indicated in the table below, which include the non-cash impact of amortization of acquired intangible assets, acquisition-related expenses, impairments, and the impact of certain expenses and other items that management believes are not indicative of longer- term business trends and operations.

represents GAAP net income recognizing the adjustments, net of tax. The Company believes that adjusted net income is helpful to investors in assessing the Company’s financial performance.

represents adjusted net income divided by weighted average common shares outstanding on a fully diluted basis.

__________________ (1) Reflects non-recurring costs associated with acquisitions, including various transaction and certain integration costs.

(2) This impairment charge results from the Company’s decision to exit the Medicare Advantage Prescription Drug product for 2027 as that product does not align with the Company’s strategic shift to focus exclusively on dual eligible members in Medicare.

(3) The nine months ended September 30, 2026 primarily includes non-recurring termination benefits, and the nine months ended September 30, 2025 includes non- recurring litigation costs. -MORE- Molina Healthcare, Inc. Reports Third Quarter 2026 Financial Results

__________________ (1) Income tax effect calculated at the statutory tax rate of approximately 25.5%.

(2) Computations assume approximately 51.4 million diluted weighted average shares outstanding. -END-

Full text with the tables
                                                                                
  News Release                                                                  
                                                                                
Investor Contact: Jeffrey Geyer, [email protected] ,
305-317-3012

Media Contact: Caroline Zubieta, [email protected] ,
562-542-1845
         Molina Healthcare Reports Third Quarter 2026 Financial Results         
                                                                                
                   Reaffirms Full Year 2026 Earnings Guidance                   
                                                                                
  Long Beach, Calif., October 21, 2026                                          
                                                                                
– Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported third
quarter 2026 GAAP income per diluted share of $0.73 and adjusted income per
diluted share of $0.89. Financial results are summarized below:
                                                                                
        Thr…                                 Nine                               
        mon…                                 mon…                               
        end…                                 end…                               
        Sep…                                 Sep…                               
         30,                                  30,                               
        2026               20…               2026               20…             
  (…                                                                            
  m…                                                                            
  e…                                                                            
  p…                                                                            
  r…                                                                            
  P…               $10…               $1…               $30…               $3…  
  R…                                                                            
  T…               $11…               $1…               $32…               $3…  
  R…                                                                            
  G…                                                                            
  N…                $38               $79               $112               $6…  
  I…                                                                            
  E…                                                                            
  –                $0.…               $1…               $2.…               $1…  
  D…                                                                            
  M…                                                                            
  C…          92…     %         92.6    %          92…     %         90.8    %  
  R…                                                                            
  (…                                                                            
  G…          6.4     %          6.4    %          6.8     %          6.5    %  
  R…                                                                            
  P…          0.5     %          0.8    %          0.5     %          2.4    %  
  M…                                                                            
  A…                                                                            
  N…                $46               $97               $243               $7…  
  I…                                                                            
  E…                                                                            
  –                $0.…               $1…               $4.…               $1…  
  D…                                                                            
  G…          6.3     %          6.3    %          6.6     %          6.4    %  
  R…                                                                            
  P…          0.6     %          1.0    %          1.1     %          2.7    %  
  M…                                                                            
  S…                                                                            
  t…                                                                            
  R…                                                                            
  of                                                                            
  U…                                                                            
  N…                                                                            
  F…                                                                            
  M…                                                                            
  at                                                                            
  t…                                                                            
  e…                                                                            
  of                                                                            
  t…                                                                            
  r…                                                                            
                                                                                
                                                                                
  Quarter Highlights                                                            
                                                                                
• As of September 30, 2026, the Company served approximately 4.9 million
members.

• Premium revenue was approximately $10.5 billion for the third quarter of 2026.

• Third quarter 2026 GAAP income per diluted share was $0.73 and adjusted income
per diluted share was $0.89.

• The Company reaffirmed its full year 2026 guidance of expected premium revenue
of approximately $42 billion and adjusted earnings of at least $5.25 per diluted
share.

“We are pleased with our third quarter results in this challenging environment
and reaffirm our full year guidance,” said Joseph Zubretsky, President and Chief
Executive Officer. “With the apparent plateauing of medical cost trend, which
remains at elevated levels, and the strength of recent rate updates for 2027, we
believe we are likely observing the beginning of the turn in Medicaid margins.”
                                     -MORE-                                     
Molina Healthcare, Inc. Reports Third Quarter 2026 Financial Results

Page 2

October 21, 2026
                                                                                
  Premium Revenue                                                               
                                                                                
Premium revenue was approximately $10.5 billion for the third quarter of 2026, a
decrease of 4% year over year. The lower premium revenue reflects the impact of
lower membership in Medicaid and Marketplace, partially offset by rate updates.
                                                                                
  Net Income                                                                    
                                                                                
GAAP net income for the third quarter of 2026 was $38 million, or $0.73 per
diluted share, a decrease of 52% year over year. Adjusted net income for the
third quarter of 2026 was $46 million, or $0.89 per diluted share, a decrease of
53% year over year. The decrease is attributed mainly to a higher consolidated
MCR.
                                                                                
  Medical Care Ratio (MCR)                                                      
                                                                                
• The consolidated MCR for the third quarter of 2026 was 92.9%.

• The Medicaid MCR for the third quarter of 2026 was 93.0% and in line with the
Company’s expectations, reflecting rate updates and stable medical cost trend.

• The Medicare MCR for the third quarter of 2026 was 93.0% and in line with the
Company’s expectations, reflecting stable medical cost trend.

• The Marketplace MCR for the third quarter of 2026 was 92.5% and in line with
normal seasonality and the Company’s expectations.
                                                                                
  General and Administrative Expense Ratio                                      
                                                                                
The G&A ratio and the adjusted G&A ratio for the third quarter of 2026 were 6.4%
and 6.3%, respectively, reflecting continued operating discipline.
                                                                                
  Balance Sheet                                                                 
                                                                                
Cash and investments at the parent company were approximately $608 million as of
September 30, 2026, compared to $223 million as of December 31, 2025.

Days in claims payable at September 30, 2026, was 44, consistent with June 30,
2026.
                                                                                
  Cash Flow                                                                     
                                                                                
Operating cash flow for the nine months ended September 30, 2026, was $629
million, compared to an outflow of $237 million for the nine months ended
September 30, 2025. The increase compared to the prior year was driven mainly by
lower government receivable and payable settlements in 2026.
                                                                                
  2026 Guidance                                                                 
                                                                                
Premium revenue guidance for the full year is unchanged at approximately $42
billion.

The Company expects its full year 2026 GAAP earnings to be at least $2.38 per
diluted share and reaffirmed its full year 2026 adjusted earnings of at least
$5.25 per diluted share. Guidance metrics across all segments are also
reaffirmed. Full year earnings guidance includes a loss of $1.50 per share due
to the implementation of the new Florida Medicaid contract in the fourth quarter
of 2026 and a loss of $1.00 per share due to performance of the traditional MAPD
product, which the Company previously announced it will exit for 2027.
                                     -MORE-                                     
Molina Healthcare, Inc. Reports Third Quarter 2026 Financial Results

Page 3

October 21, 2026
                                                                                
  Conference Call                                                               
                                                                                
Management will host a conference call and webcast to discuss Molina
Healthcare’s third quarter ended September 30, 2026 results, at 8:00 a.m.
Eastern Time on Thursday, October 22, 2026. The number to call for the
interactive teleconference is (877) 883-0383 and the confirmation number is
6534841. A telephonic replay of the conference call will be available through
Thursday, October 29, 2026, by dialing (855) 669-9658 and entering confirmation
number 4361465 . A live audio broadcast of this conference call will be
available on Molina Healthcare’s investor relations website,
investors.molinahealthcare.com . A 30-day online replay will be available
approximately an hour following the conclusion of the live broadcast.
                                                                                
  About Molina Healthcare                                                       
                                                                                
Molina Healthcare, Inc., a FORTUNE 500 company, provides managed healthcare
services under the Medicaid and Medicare programs and through the state
insurance marketplaces. For more information about Molina Healthcare, please
visit molinahealthcare.com .

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

This earnings release and the Company’s accompanying oral remarks contain
forward-looking statements. The Company intends such forward-looking statements
to be covered under the safe harbor provisions for forward-looking statements
contained in Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934. Forward-looking statements provide current
expectations of future events based on certain assumptions, and all statements
other than statements of historical fact contained in this earnings release and
the Company’s accompanying oral remarks may be forward-looking statements. In
some cases, you can identify forward-looking statements by words such as
“guidance,” “future,” “anticipates,” “assumes,” “believes,” “embedded,”
“estimates,” “expects,” “growth,” “intends,” “plans,” “predicts,” “projects,”
“will,” “would,” “could,” “can,” “may,” or the negative of these terms or other
similar expressions. Forward-looking statements contained in this earnings
release include, but are not limited to, statements regarding the Company’s 2026
guidance and long-term performance outlook, trends with respect to rates, pretax
margins, utilization, and medical costs, including the timing thereof and the
anticipated impact on the Company’s business, and our management’s plans and
objectives for future operations and business strategy.

Actual results could differ materially due to numerous known and unknown risks
and uncertainties. These risks and uncertainties are discussed under the
headings “Forward-Looking Statements,” and “Risk Factors,” in the Company’s
Annual Report on Form 10‑K for the year ended December 31, 2025, which is on
file with the U.S. Securities and Exchange Commission (the “SEC”), and in the
Company’s other filings with the SEC, including its Quarterly Reports on Form
10-Q for the period ended March 31, 2026 and June 30, 2026 filed with the SEC
and Quarterly Report on Form 10-Q for the period ended September 30, 2026, to be
filed with the SEC.

These reports can be accessed under the investor relations tab of the Company’s
website or on the SEC’s website at sec.gov . Given these risks and
uncertainties, the Company can give no assurances that its forward-looking
statements will prove to be accurate, or that any other results or developments
projected or contemplated by its forward-looking statements will in fact occur,
and the Company cautions investors not to place undue reliance on these
statements. All forward-looking statements in this release represent the
Company’s judgment as of October 21, 2026, and, except as otherwise required by
law, the Company disclaims any obligation to update any forward-looking
statement to conform the statement to actual results or changes in its
expectations.
                                     -MORE-                                     
Molina Healthcare, Inc. Reports Third Quarter 2026 Financial Results

Page 4

October 21, 2026
                                                                                
                            MOLINA HEALTHCARE, INC.                             
                                                                                
                                                                                
                  UNAUDITED CONSOLIDATED STATEMENTS OF INCOME                   
                                                                                
                                                                                
            Three                                                               
            Months                                                              
            Ended                                                               
            Septem…                                                             
            30,                                                                 
            2026                               Nine                             
            (In                                Months                           
            millio…                            Ended                            
            except                             Septem…                          
            per-sh…                            30,                              
  Reven…    amount…            2025            2026               2025          
 ────────────────────────────────────────────────────────────────────────────── 
  Premi…    $        10,457    $     10,841    $        30,873    $     32,337  
  reven…                                                                        
  Premi…                                                                        
  tax                   500             506              1,509           1,325  
  reven…                                                                        
  Inves…                102             108                301             322  
  income                                                                        
  Other                  23              22                 69              67  
  reven…                                                                        
  Total              11,082          11,477             32,752          34,051  
  reven…                                                                        
  Opera…                                                                        
  expen…                                                                        
  Medic…                                                                        
  care                9,719          10,044             28,429          29,352  
  costs                                                                         
  Gener…                                                                        
  and                   710             729              2,213           2,214  
  admin…                                                                        
  expen…                                                                        
  Premi…                                                                        
  tax                   500             506              1,509           1,325  
  expen…                                                                        
  Depre…                                                                        
  and                    38              45                117             151  
  amort…                                                                        
  Impai…                  —               —                 93               —  
  Other                   9              16                 57              66  
  Total                                                                         
  opera…             10,976          11,340             32,418          33,108  
  expen…                                                                        
  Opera…                106             137                334             943  
  income                                                                        
  Inter…                 53              49                161             140  
  expen…                                                                        
  Income                                                                        
  before                                                                        
  income                 53              88                173             803  
  tax                                                                           
  expen…                                                                        
  Income                                                                        
  tax                    15               9                 61             171  
  expen…                                                                        
  Net       $            38    $         79    $           112    $        632  
  income                                                                        
  Net                                                                           
  income                                                                        
  per       $          0.73    $       1.51    $          2.19    $      11.79  
  share                                                                         
  –                                                                             
  Dilut…                                                                        
  Dilut…                                                                        
  weigh…                                                                        
  avera…               51.5            52.5               51.3            53.6  
  shares                                                                        
  outst…                                                                        
                                                                                
                                     -MORE-                                     
Molina Healthcare, Inc. Reports Third Quarter 2026 Financial Results

Page 5

October 21, 2026
                                                                                
                            MOLINA HEALTHCARE, INC.                             
                                                                                
                                                                                
                          CONSOLIDATED BALANCE SHEETS                           
                                                                                
                                                                                
                          September 30,                                         
                          2026                                                  
                          Unaudited                                             
                          (Dollars in                                           
                          millions,                                             
  ASSETS                  except per-share                December 31,          
  Current assets:         amounts)                        2025                  
 ────────────────────────────────────────────────────────────────────────────── 
  Cash and cash           $                      4,479    $              4,248  
  equivalents                                                                   
  Investments                                    4,100                   4,008  
  Receivables                                    3,359                   3,533  
  Prepaid expenses and                                                          
  other current                                    576                     655  
  assets                                                                        
  Total current assets                          12,514                  12,444  
  Property, equipment,                                                          
  and capitalized                                  324                     301  
  software, net                                                                 
  Goodwill and                                                                  
  intangible assets,                             2,073                   2,195  
  net                                                                           
  Restricted                                       345                     299  
  investments                                                                   
  Deferred income                                  267                     178  
  taxes, net                                                                    
  Other assets                                     129                     147  
  Total assets            $                     15,652    $             15,564  
  LIABILITIES AND                                                               
  STOCKHOLDERS’ EQUITY                                                          
  Current liabilities:                                                          
  Medical claims and      $                      4,988    $              4,887  
  benefits payable                                                              
  Amounts due                                    1,141                   1,326  
  government agencies                                                           
  Accounts payable,                                                             
  accrued liabilities                            1,183                   1,093  
  and other                                                                     
  Deferred revenue                                  82                      66  
  Total current                                  7,394                   7,372  
  liabilities                                                                   
  Long-term debt                                 3,771                   3,766  
  Finance lease                                    179                     184  
  liabilities                                                                   
  Other long-term                                  153                     173  
  liabilities                                                                   
  Total liabilities                             11,497                  11,495  
  Stockholders’                                                                 
  equity:                                                                       
  Common stock, $0.001                                                          
  par value, 150                                                                
  million shares                                                                
  authorized;                                                                   
  outstanding:                                       —                       —  
  52 million shares at                                                          
  September 30, 2026,                                                           
  and 51 million at                                                             
  December 31, 2025                                                             
  Preferred stock,                                                              
  $0.001 par value; 20                                                          
  million shares                                                                
  authorized, no                                     —                       —  
  shares                                                                        
  issued and                                                                    
  outstanding                                                                   
  Additional paid-in                               536                     452  
  capital                                                                       
  Accumulated other                                                             
  comprehensive (loss)                             -95                      15  
  income                                                                        
  Retained earnings                              3,714                   3,602  
  Total stockholders’                            4,155                   4,069  
  equity                                                                        
  Total liabilities                                                             
  and stockholders’       $                     15,652    $             15,564  
  equity                                                                        
                                                                                
                                     -MORE-                                     
Molina Healthcare, Inc. Reports Third Quarter 2026 Financial Results

Page 6

October 21, 2026
                                                                                
                            MOLINA HEALTHCARE, INC.                             
                                                                                
                                                                                
                UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS                 
                                                                                
                                                                                
                                     Nine Months Ended                          
                                     September 30,                              
                                     2026                                       
  Operating activities:              (In millions)                2025          
 ────────────────────────────────────────────────────────────────────────────── 
  Net income                         $                     112    $        632  
  Adjustments to reconcile net                                                  
  income to                                                                     
  net cash provided by (used in)                                                
  operating                                                                     
  activities:                                                                   
  Depreciation and amortization                            117             151  
  Deferred income taxes                                    -54              37  
  Share-based compensation                                  85              27  
  Impairment                                                93               —  
  Other, net                                               -21              -2  
  Changes in operating assets and                                               
  liabilities:                                                                  
  Receivables                                              174            -118  
  Prepaid expenses and other                                                    
  current                                                   11             -25  
  assets                                                                        
  Medical claims and benefits                              101            -157  
  payable                                                                       
  Amounts due government agencies                         -185            -467  
  Accounts payable, accrued                                                     
  liabilities                                               88            -195  
  and other                                                                     
  Deferred revenue                                          16             -44  
  Income taxes                                              92             -76  
  Net cash provided by (used in)                                                
  operating                                                629            -237  
  activities                                                                    
  Investing activities:                                                         
  Purchases of investments                              -1,245            -607  
  Proceeds from sales and                                                       
  maturities of                                          1,020           1,017  
  investments                                                                   
  Purchases of property,                                                        
  equipment, and                                           -94            -102  
  capitalized software                                                          
  Net cash paid in business                                  —            -245  
  combinations                                                                  
  Other, net                                                -9              19  
  Net cash (used in) provided by                                                
  investing                                               -328              82  
  activities                                                                    
  Financing activities:                                                         
  Proceeds from borrowings under                                                
  credit                                                     —           1,100  
  facility and term loans                                                       
  Common stock purchases                                     —          -1,000  
  Repayment of credit facility                                                  
  and term                                                   —            -360  
  loans                                                                         
  Common stock withheld to settle                                               
  employee                                                 -15             -37  
  tax obligations                                                               
  Other, net                                               -16              35  
  Net cash used in financing                               -31            -262  
  activities                                                                    
  Net increase (decrease) in                                                    
  cash, cash                                                                    
  equivalents, and restricted                              270            -417  
  cash and                                                                      
  cash equivalents                                                              
  Cash, cash equivalents, and                                                   
  restricted                                                                    
  cash and cash equivalents at                           4,348           4,741  
  beginning                                                                     
  of period                                                                     
  Cash, cash equivalents, and                                                   
  restricted                                                                    
  cash and cash equivalents at       $                   4,618    $      4,324  
  end of                                                                        
  period                                                                        
                                                                                
                                     -MORE-                                     
Molina Healthcare, Inc. Reports Third Quarter 2026 Financial Results

Page 7

October 21, 2026
                                                                                
                            MOLINA HEALTHCARE, INC.                             
                                                                                
                                                                                
                             UNAUDITED SEGMENT DATA                             
                                                                                
                             (Dollars in millions)                              
                                                                                
             September               December              September            
                   30,                    31,                    30,            
                  2026                   2025                   2025            
  Ending                                                                        
  Member…                                                                       
  by                                                                            
  Segmen…                                                                       
  Medica…               4,372,0…               4,568,0…               4,639,0…  
  Medica…                222,000                262,000                266,000  
  Market…                267,000                655,000                713,000  
  Other                    1,000                  6,000                 10,000  
  Total                 4,862,0…               5,491,0…               5,628,0…  
                                                                                
                                                                                
        Th…                                                                     
        Mo…                                                                     
        En…                                                                     
        Se…                                                                     
        30,                                                                     
        Pr…        Me…                       Pr…        Me…                     
        Re…  2…    Ma…        MC…            Re…  2…    Ma…        MC…          
 ────────────────────────────────────────────────────────────────────────────── 
  M…    $    8…    $    5…         9…  %     $    8…    $    6…         9…  %   
  M…         1…         1…         9…             1…         1…         9…      
  M…         6…         48         9…             1…         53         9…      
  O…          —          —             NM         19          2             NM  
  C…    $    1…    $    7…         9…  %     $    1…    $    7…         9…  %   
                                                                                
                                                                                
        N…                                                                      
        M…                                                                      
        E…                                                                      
        S…                                                                      
        3…                                                                      
        P…         M…                        P…         M…                      
        R…  20…    M…         M…             R…  20…    M…         M…           
 ────────────────────────────────────────────────────────────────────────────── 
  M…    $   24…    $   1,…        92…  %     $   24…    $   2,…        91…  %   
  M…        4,…        413        91…            4,…        436        90…      
  M…        1,…        233        88…            3,…        411        87…      
  O…          6          5             NM         76         11             NM  
  C…    $   30…    $   2,…        92…  %     $   32…    $   2,…        90…  %   
  (…                                                                            
  M…                                                                            
  r…                                                                            
  m…                                                                            
  c…                                                                            
  as                                                                            
  a                                                                             
  p…                                                                            
  of                                                                            
  p…                                                                            
  r…                                                                            
  (…                                                                            
  T…                                                                            
  O…                                                                            
  M…                                                                            
  a…                                                                            
  n…                                                                            
  m…                                                                            
                                                                                
                                     -MORE-                                     
Molina Healthcare, Inc. Reports Third Quarter 2026 Financial Results

Page 8

October 21, 2026
                                                                                
                            MOLINA HEALTHCARE, INC.                             
                                                                                
                                                                                
                 CHANGE IN MEDICAL CLAIMS AND BENEFITS PAYABLE                  
                                                                                
                             (Dollars in millions)                              
The Company’s claims liabilities include additional reserves to account for
moderately adverse conditions based on historical experience and other factors
including, but not limited to, variations in claims payment patterns, changes in
utilization and cost trends, known outbreaks of disease, and large claims. The
Company’s reserving methodology is consistently applied across all periods
presented. The amounts displayed for “Components of medical care costs related
to: Prior year” represent the amounts by which the original estimates of claims
and benefits payable at the beginning of the year were more than the actual
liabilities based on information (principally the payment of claims) developed
since those liabilities were first reported. The following table presents the
components of the change in medical claims and benefits payable for the periods
indicated:
                                                                                
                                     Nine Months Ended                          
                                     September 30,                              
                                     2026                                       
                                     Unaudited                    2025          
 ────────────────────────────────────────────────────────────────────────────── 
  Medical claims and benefits                                                   
  payable,                           $                   4,887    $      4,640  
  beginning balance                                                             
  Components of medical care                                                    
  costs related                                                                 
  to:                                                                           
  Current year                                          28,781          29,476  
  Prior year                                              -352            -124  
  Total medical care costs                              28,429          29,352  
  Payments for medical care costs                                               
  related                                                                       
  to:                                                                           
  Current year                                          24,692          25,425  
  Prior year                                             3,963           4,059  
  Total paid                                            28,655          29,484  
  Acquired balances, net of                                  —             361  
  post-acquisition adjustments                                                  
  Change in non-risk and other                             327             -25  
  payables                                                                      
  Medical claims and benefits                                                   
  payable,                           $                   4,988    $      4,844  
  ending balance                                                                
  Days in Claims Payable(1)                                 44              46  
                                                                                
__________________

(1) The Company calculates Days in Claims Payable using claims incurred but not
paid, or IBNP, and other fee-for-service payables included in medical claims and
benefits payable, and quarterly fee-for-service related costs included in
medical care costs within the Company’s consolidated financial statements.
                                     -MORE-                                     
Molina Healthcare, Inc. Reports Third Quarter 2026 Financial Results

Page 9

October 21, 2026
                                                                                
                            MOLINA HEALTHCARE, INC.                             
                                                                                
                                                                                
            RECONCILIATION OF UNAUDITED NON-GAAP FINANCIAL MEASURES             
                                                                                
                (In millions, except per diluted share amounts)                 
The Company believes that certain non-GAAP (generally accepted accounting
principles) financial measures are useful supplemental measures to investors in
comparing the Company’s performance to the performance of other public companies
in the health care industry. The non-GAAP financial measures are also used
internally to enable management to assess the Company’s performance consistently
over time. These non-GAAP financial measures, presented below, should be
considered as supplements to, and not as substitutes for or superior to, GAAP
measures.
                                                                                
  Adjustments                                                                   
                                                                                
represent additions and deductions to GAAP net income as indicated in the table
below, which include the non-cash impact of amortization of acquired intangible
assets, acquisition-related expenses, impairments, and the impact of certain
expenses and other items that management believes are not indicative of longer-
term business trends and operations.
                                                                                
  Adjusted G&A Ratio                                                            
                                                                                
represents the GAAP G&A ratio, recognizing adjustments.
                                                                                
  Adjusted net income                                                           
                                                                                
represents GAAP net income recognizing the adjustments, net of tax. The Company
believes that adjusted net income is helpful to investors in assessing the
Company’s financial performance.
                                                                                
  Adjusted net income per diluted share                                         
                                                                                
represents adjusted net income divided by weighted average common shares
outstanding on a fully diluted basis.
                                                                                
  Adjusted pre-tax margin                                                       
                                                                                
represents adjusted income before income tax expense, divided by total revenue.
                                                                                
      …                                         …                               
      …                                         …                               
      …                                         …                               
      …       …                    …            …       …                       
      …       …                    …            …       …                       
      …       …       …    …       …       …    …       …      …                
 ────────────────────────────────────────────────────────────────────────────── 
      $  …    $  …         $  …    $  …         $  …    $             …      …  
                                                                                
      $  …    $  …         $  …    $  …         $  …    $             …      …  
         —       —            4       …            …                  …      …  
         —       —            —       —            …                  —      —  
         —       —            …       …            …                  1      …  
         …       …            …       …            …                  …      …  
         …       …            …       …            …                  …      …  
         8       …            …       …            …                  …      …  
      $  …    $  …         $  …    $  …         $  …    $             …      …  
                                                                                
__________________
(1) Reflects non-recurring costs associated with acquisitions, including various
transaction and certain integration costs.

(2) This impairment charge results from the Company’s decision to exit the
Medicare Advantage Prescription Drug product for 2027 as that product does not
align with the Company’s strategic shift to focus exclusively on dual eligible
members in Medicare.

(3) The nine months ended September 30, 2026 primarily includes non-recurring
termination benefits, and the nine months ended September 30, 2025 includes non-
recurring litigation costs.
                                     -MORE-                                     
Molina Healthcare, Inc. Reports Third Quarter 2026 Financial Results

Page 10

October 21, 2026
                                                                                
                            MOLINA HEALTHCARE, INC.                             
                                                                                
      RECONCILIATION OF UNAUDITED NON-GAAP FINANCIAL MEASURES (CONTINUED)       
                                                                                
                                 2026 GUIDANCE                                  
                                                                                
                                                                          
                                                      Per Diluted         
                                       Amount         Share(2)            
 ──────────────────────────────────────────────────────────────────────── 
  GAAP Net income                      $       122    $             2.38  
  Adjustments:                                                            
  Acquisition-related expenses                  48                  0.89  
  Amortization of intangible assets             36                  0.70  
  Impairment                                    93                  1.82  
  Other                                         21                  0.44  
  Subtotal, adjustments                        198                  3.85  
  Income tax effect(1)                         -50                 -0.98  
  Adjustments, net of tax                      148                  2.87  
  Adjusted net income                  $       270    $             5.25  
                                                                          
__________________
(1) Income tax effect calculated at the statutory tax rate of approximately
25.5%.

(2) Computations assume approximately 51.4 million diluted weighted average
shares outstanding.
                                     -END-                                      

Sources

The 8-K item 2.02 filings (SEC EDGAR) and their EX-99 exhibits: the results release and, when filed, prepared remarks or the call transcript.

Also

Said vs did: the targets in these releases against what was then reported. Filings: every filing.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/MOH/export.csv") into a cell.

Next:Presentations
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.